[Skip to Navigation]
[Skip to Navigation Landing]
Original Investigation
October 22, 2020

Association Between Olfactory Dysfunction and Mortality in US Adults

Author Affiliations
  • 1Caruso Department of Otolaryngology–Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles
  • 2Royal College of Surgeons in Ireland, Dublin
  • 3Department of Otolaryngology–Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
JAMA Otolaryngol Head Neck Surg. 2021;147(1):49-55. doi:10.1001/jamaoto.2020.3502
Key Points

Question  Is self-reported and/or objectively measured olfactory dysfunction associated with mortality when accounting for relevant factors among adults in the United States?

Findings  In this nationally representative cohort study of 3503 adults 40 years or older, objectively measured olfactory dysfunction was significantly associated with increased all-cause 5-year mortality among older adults independent of demographics, cardiovascular comorbidities, depression, and cognition (18% increased risk per 1-point decrease in Pocket Smell Test score [score range, 0-8]). Self-reported olfactory dysfunction was not associated with mortality.

Meaning  These findings suggest that objectively measured olfactory dysfunction is robustly associated with 5-year mortality among older US adults, and olfaction measured by objective smell test may be a useful indicator of health status in older adults.

Abstract

Importance  A study of olfactory dysfunction and mortality in a large national cohort will aid in better understanding their association when accounting for multiple relevant factors and possible underlying mechanisms.

Objective  To investigate the association of olfactory dysfunction with all-cause 5-year mortality in US adults.

Design, Setting, and Participants  This cohort study included participants 40 years or older from the 2013-2014 National Health and Nutritional Examination Survey who had data on olfaction and mortality (n = 3503). Olfaction was assessed by self-report and objective test (8-odor Pocket Smell Test). Mortality was determined by linking with the National Death Index through February 24, 2019. Data were analyzed from July 1 to September 30, 2019.

Main Outcomes and Measures  Olfaction and 5-year mortality. Cox proportional regression models were used to examine the associations between olfaction and mortality while adjusting for demographics and medical comorbidities. Multivariate models were further adjusted for depression and cognitive assessments.

Results  Among the 3503 participants (1831 women [52.3%]; mean [SD] age, 59.0 [12.0] years), the prevalence of olfactory dysfunction was 13.5% (95% CI, 11.0%-16.0%) based on results of an objective smell test and 21.6% (95% CI, 18.9%-24.2%) based on self-report. Risk of mortality increased by 18% (95% CI, 7%-29%) per 1-point decrease in smell test score in a multivariate model. The association was significant among adults 65 years or older in association with binary (hazard ratio [HR], 1.95; 95% CI, 1.19-3.21) and linear (HR, 1.19; 95% CI, 1.08-1.31) measures of objective olfactory dysfunction, but not among adults aged 40 to 64 years. There was no association between self-reported olfactory dysfunction and mortality. The association between objective olfactory dysfunction and mortality remained after further adjusting for cognitive assessment battery and depression among older adults (HR, 1.18; 95% CI, 1.01-1.37).

Conclusions and Relevance  These findings suggest that objective olfactory dysfunction is associated with increased mortality among older adults. In addition to its effect on quality of life, the association of olfactory dysfunction with mortality has implications for physical and cognitive health.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×